JP2012255026A5
(enrdf_load_stackoverflow )
2013-02-21
JP2012031131A5
(enrdf_load_stackoverflow )
2013-03-14
JP2010047612A5
(enrdf_load_stackoverflow )
2012-01-05
JP2007302683A5
(enrdf_load_stackoverflow )
2008-07-31
ATE543489T1
(de )
2012-02-15
Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
JP2009537554A5
(enrdf_load_stackoverflow )
2010-07-01
HRP20161577T1
(hr )
2017-01-27
Inhibitori replikacije virusa gripe
JP2003520232A5
(enrdf_load_stackoverflow )
2008-03-13
JP2005512997A5
(enrdf_load_stackoverflow )
2006-01-05
JP2012031147A5
(enrdf_load_stackoverflow )
2013-03-14
JP2003503454A5
(enrdf_load_stackoverflow )
2007-06-07
JP2007238598A5
(enrdf_load_stackoverflow )
2009-08-20
GEP20084468B
(en )
2008-08-25
Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it
JP2007520565A5
(enrdf_load_stackoverflow )
2008-04-03
JP2011527299A5
(enrdf_load_stackoverflow )
2013-10-17
JP2009505991A5
(enrdf_load_stackoverflow )
2009-08-20
WO2008116601A3
(en )
2009-07-23
Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
JP2013166781A5
(enrdf_load_stackoverflow )
2013-10-10
JP2008513510A5
(enrdf_load_stackoverflow )
2011-01-06
HRP20171742T4
(hr )
2021-08-06
2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
JP2006342148A5
(enrdf_load_stackoverflow )
2008-06-19
JP2008515980A5
(enrdf_load_stackoverflow )
2008-11-27
CA2489140A1
(en )
2004-11-18
Dosage form containing pantoprazole as active ingredient
TR201001417A1
(tr )
2011-09-21
Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu
JP2011516544A5
(enrdf_load_stackoverflow )
2013-08-01